Malaysian PE firm Ekuinas acquires 80% stake in pharma player Symbiotica

Malaysian PE firm Ekuinas acquires 80% stake in pharma player Symbiotica

Ekuinas CEO Syed Yasir Arafat Syed Abd Kadir at DEALSTREETASIA's PE-VC Summit 2018 in Singapore.

Edited by: Padma Priya

EkuinasSymbiotica

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Malaysia

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.